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Background and Significance 
Endoplasmic Reticulum translocation is essential to eukaryotic function 
While most protein synthesis is isolated to the cytosol of the eukaryotic cell, proteins are needed 
throughout the cell, as well as exported outside the cell. Proteins bound for the cellular membrane or 
exported outside the cell are trafficked through a series of membranes, organelles, and vesicles. These 
structures are collectively known as the endomembrane system (Park and Rapoport 2012). The 
endoplasmic reticulum (ER) is an entry point for a variety of proteins bound for the endomembrane 
system (Aviram and Schuldiner 2017). Over 30% of proteins synthesized by the cell use the ER to travel 
to their place of effect (Chen et al. 2005). The ER is also responsible for post-translational processing, 
containing many enzymes responsible for modifying proteins once they have entered the ER (Schwarz 
and Blower 2016).  
The foremost entrance into the ER is the translocon. The translocon is a protein complex centered 
around Sec61 (Plath et al. 1998). Sec61, along with Sss1 and Sbh1 create a pore allowing the passage of 
polypeptides into the ER, where they fold and are modified into their functional configurations 
(Deshaies and Schekman 1987).  
Translocation of polypeptides may occur by one of two primary mechanisms: co-translational 
translocation (CTT) or post-translational translocation (PTT) (Figure 1). CTT involves recruitment of an 
actively translating ribosome to the translocon (Ast, Cohen, and Schuldiner 2013).  This is done through 
a signal recognition particle (SRP) that binds to the newly synthesized protein. Through interactions with 
the SRP receptor, the translating ribosome is lead to the Sec61 pore, and the protein is translocated as 
the ribosome continues to synthesize it (Linxweiler, Schick, and Zimmermann 2017). 
PTT occurs when a protein is completely translated in the cytosol and then translocated into the ER 
lumen. This requires a set of accessory proteins that are not required for CTT. Cytosolic Hsp40 and 
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Hsp70 proteins escort newly synthesized proteins to the translocon complex. This stabilizes proteins and  
prevents folding that would hinder movement through the translocon (Kimura, Yahara, and Lindquist 
1995; Cyr and Douglas 1994). In addition to the Sec61/Sss1/Sbh1 heterotrimer, the membrane-bound 
tetramer composed of Sec62, Sec63, Sec71, and Sec72 are also essential for PTT substrates to bind the 
translocon complex and travel into the lumen of the ER.  Recent data suggest Sec62 and Sec63 may also 
be involved in CTT (Linxweiler, Schick, and Zimmermann 2017). 
Dysfunction of the translocon occurs when proteins are unable to pass through the Sec61 channel and 
enter the ER. This dysfunction has extensive effects for human health, including links to kidney disease, 
liver disease,  type 1 diabetes, and cancer (Lang et al. 2017). For example, mutations in Sec63 cause 
dysfunction in CTT that limits the movement of polycystins into the ER, which in turn leads to 
autosomal-dominant polycystic liver disease (Drenth et al. 2005), and translocon clogging has been 
proposed as a mechanism that contributes to diabetes (Kayatekin et al. 2018). The relationship between 
translocon dysfunction and disease is not entirely understood. 
Yeast is a useful model organism to study translocons  
This work utilizes the model organism Saccharomyces cerevisiae (budding yeast) to study protein quality 
control at the translocon. Yeast contain several traits that can be advantageous for experiments 
performed to understand fundamental eukaryotic biology. Yeast grow at fast rates and are cost-
effective compared to mammalian cell culture (Duina, Miller, and Keeney 2014). Translocation and 
translocon quality control are conserved in yeast and in humans (Lang et al. 2017; Kaneko et al. 2016; 
Joshi et al. 2017; Fisher, Khanna, and McLeod 2011; Ast, Michaelis, and Schuldiner 2016; Crowder et al. 
2015; Vibhuti Joshi 2017). Discoveries in yeast are therefore likely to be relevant to human physiology.   
 
Cells can remove proteins that aberrantly interact with the translocon  
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One cause of translocon dysfunction is when proteins aberrantly interact with the translocon and stall in 
the pore of Sec61 (Rubenstein et al. 2012). This stalling blocks translocation of other proteins through 
the translocon pore until the offending protein is removed (Ast, Michaelis, and Schuldiner 2016; Toshiaki 
Izawa 2012). This clogging dysfunction can occur during either PTT (Rubenstein et al. 2012) or CTT 
(Crowder et al. 2015). 
Cells have multiple mechanisms for removing proteins that aberrantly stall in the translocon. One of 
these mechanisms centers around homologs of the enzyme Hrd1 (Deak and Wolf 2001). Hrd1 is a 
ubiquitin ligase (E3) that acts as part of the ubiquitin-proteasome system (UPS; Figure 2) (Nandi et al. 
2006). In the UPS, a ubiquitin-activating enzyme (E1) transfers the small signaling molecule ubiquitin to a 
ubiquitin-conjugating enzyme (E2) (Mayor 2014). The ubiquitin-conjugating enzyme is then recruited to 
the targeted substrate by an E3. The E3 is responsible for facilitating the transfer of the ubiquitin from 
the E2 to the substrate. E3 ligases may transfer ubiquitin molecules to another ubiquitin molecule, 
creating chains of ubiquitin molecules on a targeted substrate. For a protein to be targeted by the UPS, 
multiple ubiquitin molecules must be added to the substrate. Once the protein has been 
polyubiquitylated, it is degraded by the proteasome (Tommer Ravid 2008). After the protein has been 
degraded, the amino acid components can be recycled for new protein synthesis, and the free ubiquitin 
molecules can be reused in the UPS (Zhangyuan Yin 2020). In the case of removing clogged proteins 
from the translocon, members of the Hrd1 family of ubiquitin ligases transfer ubiquitin molecules to 
aberrant proteins in the translocon channel (Figure 3) (Rubenstein et al. 2012). This mechanism is 
conserved from yeast to mammals, with the mammalian Hrd1 homolog Gp78 targeting the translocon-
clogging protein apolipoprotein B (apoB, discussed below).  
Another major mechanism for removing stalled proteins from the translocon is Ste24 (Figure 4). Ste24 is 
a metalloprotease which cleaves stalled proteins in the translocon (Ast, Michaelis, and Schuldiner 2016). 
Once cleaved, the cytosolic portion becomes unbound from the translocon and is targeted by the 
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proteasome for degradation. The luminal section of the stalled protein, now also free from the 
translocon, is believed to continue into the lumen of the ER, where it may be eventually signaled for 
degradation by the proteasome (Ast, Michaelis, and Schuldiner 2016). This mechanism is conserved 
between yeast and humans (Ast, Michaelis, and Schuldiner 2016).  
Hrd1 and Ste24 are both important in the removal of aberrant post-translationally translocated proteins. 
Proteins may also stall through aberrant interaction with the ribosome during CTT. For example, if the 
stop codon signal in an mRNA molecule is missed, translation will continue into the 3’ untranslated 
region and, unless a stop codon is fortuitously detected, into the poly-A tail (Bennett 2014). A ribosome 
that aberrantly skips the stop codon will begin to translate poly-A tail. This creates a polylysine chain at 
the end of the normal amino acid sequence. These lysine residues aberrantly interact with the internal 
ribosomal structure, causing the protein to stall in not only the ribosomal machinery, but in the 
translocon as well, if the protein is ER-targeted (Crowder et al. 2015; Malsburg, Shao, and Hegde 2015). 
The E3 ligase responsible for ubiquitylation and removal of these ribosomal stalled proteins is Rkr1/Ltn1 
(Figure 5). Rkr1/Ltn1 function in targeting ER-targeted CTT substrates is conserved between yeast and 
mammals (Karina von der Malsburg 2015). 
Model proteins engineered to stall in the translocon are used due to absence of characterized natural 
proteins that stall in the translocon 
There are a limited number of characterized natural proteins known to stall in the translocon. In 
humans, the low-density lipoprotein (LDL) precursor apolipoprotein B (apoB) is known to stall in the 
translocon as it waits for available lipids. If no lipids are available, the enzyme Gp78 (a mammalian Hrd1 
homolog (Vibhuti Joshi 2017)) targets translocon-associated apoB for degradation, allowing for normal 
translocon function to resume (Yeung, Chen, and Chan 1996). Thus, removal of aberrant proteins from 
the translocon can also serve a regulatory function, as well as a quality control function.  
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ApoB is toxic to yeast, making it a poor model for studies of translocon quality control in a yeast model 
system (Eric Rubenstein, unpublished data). Two model substrates are used for studying protein quality 
control at the yeast translocon: Deg1-Sec62 and Clogger (Figure 6). Deg1-Sec62 is an engineered protein 
with the two-transmembrane protein Sec62 fused to the N-terminal 67 residues of the protein Matα2 
(Deg1) (Rubenstein et al. 2012). When Deg1-Sec62 is first translated, the two transmembrane segments 
of the protein enter the translocon and are integrated into the ER membrane. Once the protein is fully 
integrated, persistent interaction with the translocon allows for a portion of the N-terminal tail to post-
translationally translocate into the ER lumen. This interaction is stabilized by a disulfide bond between 
Deg1-Sec62 and the interior of the translocon. Only a portion of Deg1-Sec62 is able to translocate into 
the ER lumen, causing the protein to aberrantly stall in the translocon (Rubenstein et al. 2012). Hrd1 
plays the major role in targeting Deg1-Sec62 for degradation (Rubenstein et al. 2012). However, Ste24 
has also been shown to promote degradation of this protein, although to a smaller extent (Runnebohm 
et al. 2020). In this study, we also use a variant of Deg1-Sec62 that contains point mutations. This 
version of Deg1-Sec62 (denoted as Deg1*-Sec62) has been shown to behave the same as “normal” 
Deg1-Sec62 during clogging experiments (Rubenstein et al. 2012). The point mutations in Deg1*-Sec62 
have the added advantage of preventing clogging protein from being degraded by other quality control 
mechanisms independent of translocon clogging.  
Clogger is also an engineered protein, created by fusing the PTT substrate Pdi1, to the E. coli enzyme 
dihydrofolate reductase (DHFR). The DHFR portion of the protein creates a rapid and stable fold that 
cannot pass through the translocon. The protein is engineered to possess multiple N-linked glycosylation 
sites. If these sites are exposed to the ER lumen, they are modified, allowing discernment of cytosolic, 
clogged, and fully translocated protein via mobility differences as observed in sodium dodecyl sulfate-
polyacrylamide (SDS-PAGE) and western blot experiments. Clogger was initially believed to be 
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specifically degraded by Ste24. However, Hrd1 has also been shown to promote Clogger degradation 
(Runnebohm et al. 2020).  
The relationship between protein quality control mechanisms at the ER is unclear 
Unexpectedly, deleting either HRD1 or STE24 does not cause a growth defect (Crowder et al. 2015; Ast, 
Michaelis, and Schuldiner 2016). If translocon quality control is critical to cellular homeostasis, then we 
would expect to observe negative phenotypes associated with impaired mechanisms. Our hypothesis 
was this observation is due to redundancy between the two quality control mechanisms. This was 
supported by the observation that hrd1Δ ste24Δ double mutant cells exhibit a synthetic slow-growth 
phenotype (Figure 7A) (Runnebohm et al. 2020).  
The addition of a 13myc epitope tag to Sec61 reduces translocon clogging by a model substrate 
The engineered proteins Deg1*-Sec62 and Clogger have played a large role in the research of translocon 
quality control. However, knowledge of natural proteins that stall in the translocon would allow for a 
deeper understanding of the mechanisms that control translocon quality control, and the protein 
features that lead to clogging. One way to identify novel translocon-clogging substrates would be to 
purify translocons from cells with dysfunctional quality control mechanisms. From these purified 
translocons, it may be possible to identify associated translocon-clogging proteins.  
To purify translocons, a 13myc tag was added to Sec61 in hrd1Δ ste24Δ yeast. Epitope tags such as 
13myc are useful tools in studying protein abundance and interactions, particularly when antibodies 
that bind directly to a protein of interest are not commercially available. This modification had two 
unexpected effects. hrd1Δ ste24Δ cells expressing 13myc-tagged Sec61 grew better than the double 
knockout cells that did not contain the tag, effectively rescuing cells lacking these translocon quality 
control mechanisms (Figure 7A). Biochemically, the addition of the tag also impaired clogging by Deg1*-
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Sec62, which occurs by PTT (Figure 7B). This was surprising because a previous report indicated the 
13myc tag does not impair translocon function (Carvalho, Stanley, and Rapoport 2010). 
I hypothesized that selective impairment of translocation seen in sec61-13myc hrd1Δ ste24Δ cells was 
due to dysfunction of PTT. It is possible that weaker interactions between translocating proteins and the 
translocon caused by this tag also increased viability of cells lacking translocon quality control 
mechanisms, since Hrd1 and Ste24 target model translocon-clogging proteins that engage the 
translocon post-translationally. Reduced protein clogging at the translocon would reduce cells’ 
dependence on unclogging mechanisms such as Hrd1 and Ste24. If this hypothesis is correct, then cells 
with PTT impaired in other ways should also exhibit similar phenotypes to cells containing sec61-13myc.  
I also hypothesized that tagging the translocon with a different epitope tag such as GFP and moving the 
tag farther from the central channel may improve translocon function. This approach may allow for 
isolation of proteins that naturally interact with the translocon without impairing translocon function. 
Identification of novel clogging proteins could reveal features of proteins that render them more likely 
to clog the translocon and enable elucidation of mechanisms in translocon dysfunction and repair. This 
in turn may lead to new discoveries about protein quality control at the ER and the implications these 
mechanisms have on cellular health.  
In this study, I investigated the relationship between translocon function and translocon quality control 
mechanisms. I hypothesized that the 13myc on the Sec61 subunit of the translocon rescues the 
phenotype associated with loss of HRD1 and STE24 by impairing PTT. I tested this by causing PTT 
dysfunction through elimination of the Sec72 subunit of the translocon and measuring the effect this 
has on ER import of various translocation substrates and on the hrd1 ste24 synthetic phenotype. I 
also attempted to tag the translocon in a way that perturbs function less than the 13myc tag on Sec61. 
By testing the effects of a different epitope tag, GFP, on different translocon subunits, I hoped to 
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identify a tagged translocon with wild type function, which would be useful for future experiments to 
identify natural translocon-clogging proteins. This study shows deletion of SEC72 causes impairment of 
model PTT substrates similar to impairment seen in sec61-13myc cells. Additionally, deletion of SEC72 
paired with deletion of HRD1 and STE24 rescued the negative growth phenotype seen in hrd1Δ ste24Δ 
cells. This shows a novel relationship between the translocon and translocon quality control machinery, 
in which impairment of translocon interactions reduces cells’ reliance on pathways that relieve 
translocon clogging. Translocon modifications involving GFP resulted in a variety of translocation 
phenotypes. While no translocon modification tested impaired translocation of a model CTT substrate, 
only two of the six tested GFP-tagged translocon subunits, Sec71-GFP and Sec72-GFP, showed no 
impairment of model PTT substrates. These two modifications may be useful in future experiments to 
isolate natural translocon-clogging substrates. Discovery of novel translocon-clogging proteins can lead 
to a better understanding of the foundational mechanisms behind diseases such as liver disease, 





Aim 1: To determine the effect of compromised post-translational translocation on cells with impaired 
translocon quality control. 
Hypothesis: Impaired post-translational translocation will lead to fewer clogging-prone proteins 
interacting with the translocon, which will in turn reduce reliance on protein quality control at 
the translocon.  
Aim 2: To determine the impact of epitope tags on various translocon subunits on co-translational and 
post-translational translocation. 
Goal: Identify an epitope tag that, when attached to the translocon, causes the least impairment 






Plasmid DNA Isolation 
A QIAprep (Qiagen) spin miniprep kit was used to isolate plasmid DNA from bacterial cells. Manufacturer 
instructions were used for this protocol. Plasmids used in this study are presented in Table 1. 
Bacterial culture 
Bacterial strains were stored at -70oC when not in use. Cells were cultured at 37C in Luria broth (0.5% 
Bacto yeast extract, 1% tryptone 0.5% sodium chloride) plates containing ampicillin (100 µg/ml) for 
plasmid selection.  
Yeast culture 
Yeast strains were stored at -70oC when not in use. Cells were cultured on plates containing yeast 
peptone dextrose (YPD) media (1% Bacto yeast extract, 2% Bacto peptone, 2% glucose, 0.002% adenine; 
2% agar) at 30oC. Yeast strains used in this study are presented in Table 2. To select by auxotrophic 
marker, cells were grown on plates containing synthetic dextrose (SD) media (0.67% yeast extract 
without amino acids, 2% glucose, 0.2% arginine, 0.6% isoleucine, 0.1% histidine, 0.6% leucine, 0.4% 
lysine, 0.1% methionine, 0.6% phenylalanine, 0.5% threonine, 0.4% tryptophan, 0.002% adenine, 0.002% 
uracil; 2% agar) lacking the appropriate metabolite at 30oC.  
Lithium Acetate Transformation of Yeast Strains with Plasmids   
To transform plasmid DNA into a yeast strain, yeast cells were cultured in liquid YPD media overnight at 
30oC. 500 µl of cell culture were pelleted by centrifugation at 5000 rpm for 2 minutes. Cells were 
washed with 1 ml of sterile water and pelleted again under the same conditions. Cells were resuspended 
in LTE (10 mM Tris-Cl pH 7.5, 1 mM EDTA, 0.1 M lithium acetate). 20 µl of salmon sperm DNA (100 
µg/ml) and 1 µl of plasmid DNA was added to the cell suspension. This mixture was incubated at room 
17 
 
temperature for 30 minutes. 400 µl of 40% polyethylene glycol (PEG) in LTE was added, and the mixture 
incubated again at room temperature overnight.  Cells were pelleted by centrifugation at 5000 rpm for 2 
minutes. Cell were resuspended in 50 µl of 1 M sorbitol and plated onto selective SD media.  
Yeast DNA Preparation 
A Yeast DNA Purification Kit (Masterpure) was used to isolate DNA from yeast cells. Manufacturer 
instructions were used for this protocol.   
PCR 
For preparative PCR for gene replacement, the following were combined in a PCR tube: Thermopol 
buffer, deoxynucleotide triphosphates (500 nM each), Taq polymerase (0.04 units/ml), 2 µl of template 
yeast DNA, and primers (1 µM each) engineered to match the DNA product. Template DNA was 
amplified using a thermocycler using the following conditions: 1 cycle at 95oC for 5 minutes; 40 cycles of 
95oC for 30 seconds, 55oC for 30 seconds, 72oC for 1 minute; and 1 cycle at 72oC for 10 minutes. 
For PCR genotyping, the following reagents was combined in a PCR tube: Thermopol buffer, 
deoxynucleotide triphosphates (500 nM each), Taq polymerase (0.04 units/ml), 2.5 l of template yeast 
DNA, primers (1 µM each) engineered amplify either the wild type or mutant alleles. Template DNA was 
amplified in a thermocycler using the following conditions: 1 cycle 1 at 95oC for 5 minutes; 40 cycles of 
95oC for 30 seconds, 55oC for 30 seconds, 72oC for 1 minute; and 1 cycle at 72oC for 10 minutes. 
All PCR products were verified using 1% agarose gel electrophoresis.  
DNA purification 
A QIAquick Gel Extraction Kit (Qiagen) was used to purify DNA products created via PCR. The 
manufacturer’s instructions were used for this protocol.  
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Strain Generation via High-Efficiency Transformation and Homologous Recombination 
Yeast cells were cultured in liquid YPD media overnight at 30oC. Cells were diluted to OD600 of 0.2 and 
incubated at 30oC until mid-logarithmic growth. Cells were pelleted via centrifugation at 3500 rpm for 7 
minutes. The supernatant was removed, and cells washed with 25 ml of sterile water and pelleted again. 
The supernatant was removed again, and cells resuspended in 1 ml of 0.1 M lithium acetate. Cells were 
pelleted and the supernatant removed and replaced by 400 µl of 0.1 M lithium acetate. 100 µl of this 
cell suspension was aliquoted to a microcentrifuge tube and the following added sequentially: 240 µl 
50% (w/v) PEG, 36 µl 1.0 M lithium acetate, 20 l fresh salmon sperm DNA (100 µg/ml), and PCR product 
containing an antibiotic-resistance gene flanked with sequences homologous to the target gene. This 
mixture was subjected to heat shock at 42oC for 40 minutes. Cells were pelleted at 10,000 rpm for 30 
seconds and the supernatant removed. Cells were resuspended in sterile water and plated onto YPD. 
Plates were incubated at 30oC. Plates were replica plated onto selective media and incubated until 
colonies formed. Gene replacement was confirmed by PCR.  
Strain Generation via Mating and Sporulation 
Novel strains were created by mixing two strains, each containing different desired characteristics, onto 
a YPD plate. This plate was incubated overnight at 30oC. These strains have opposite mating types, 
allowing them to form a diploid containing all desired traits. Selection was performed by plating on 
media that only allowed the diploid strain (but not either haploid strain) to grow. Sporulation was 
induced by first replica plating the diploid colonies onto a GNA plate (5% glucose 3% Difco nutrient 
broth, 1% yeast extract, 2% bacto agar) and incubating overnight at 30oC. Cells were replica plated onto 
a second GNA plate and incubation was repeated. Diploid cells were replica plated onto a sporulation 
plate (1% potassium acetate, 0.004% w/v uracil, 10 µl/L histidine, 10 µl/L leucine, 2% bacto agar). Cells 
were incubated at room temperature until tetrads form, as judged by microscopic investigation. Tetrads 
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were dissected on a YPD plate and incubated at 30oC until colonies form. Relevant genotypes were 
determined by growth on selective medium and PCR.  
Yeast Cell Lysis 
Strains were incubated in selective liquid media overnight at 30oC. Strains were diluted to an OD600 of 
0.2 and incubated again at 30oC until cultures reached mid-logarithmic phase. 2.5 OD600 units were 
collected and pelleted in a centrifuge at 7000 rpm for 30 seconds. The supernatant was removed, and 
cells resuspended in 200 l of 0.1 M sodium hydroxide. After 5 minutes incubation at room 
temperature, samples were centrifuged at 13,000 rpm for 30 seconds. The supernatant was removed, 
and samples resuspended in 100 µl Laemmli loading buffer, which lyses cells. Lysates were heated at 
95oC for five minutes and then centrifuged at 13,000 rpm for 30 seconds to pellet insoluble material.   
Endoglycosidase H (Endo H) Assay  
80 µl of yeast lysates lysate were combined with 8.4 µl 0.83 M potassium acetate (pH 5.6) and 1 l Endo 
H (0.5 units/ml) (New England BioLabs). This mixture was incubated at 37oC for 1-3 hours.  
Western Blot  
Lysates were loaded onto an 8% SDS-PAGE gel. Samples were run at 200 V. Proteins were transferred 
from the polyacrylamide gel to a polyvinylidene fluoride (PVDF) membrane that had been activated with 
methanol and submersed in transfer buffer (2.5 mM tris acetate, 1.4% w/v glycine, 0.1% w/v SDS, 20% 
methanol) at 20V for 60 min at 4C. After proteins were transferred to the PVDF membrane, the 
membrane was soaked in blocking solution (5% powdered milk in 5 mM Tris-buffered saline (TBS; 0.5 M 
Tris-Base, 1.5 M NaCl) overnight. 
AlexaFluor-680-conjugated rabbit anti-mouse antibody (Life Technologies Inc; 1:40,000) was used to 
detect Deg1*-Sec62 (which possesses two copies of Staphylococcus aureus Protein A, which binds non-
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specifically to mammalian antibodies (Hjelm 1972). Pgk1 was detected with mouse anti-
phosphoglycerate kinase 1 (Pgk1; clone 22C5D8; Life Technologies, Inc; 1:20,000) followed by 
AlexaFluor-680-conjugated rabbit anti-mouse antibody (1:40,000). Clogger was detected with mouse 
anti-HA (Life Technologies Inc.; 1:5,000) followed by AlexaFluor-680-conjugated rabbit anti-mouse 
antibody (1:40,000). GFP was detected with mouse anti-GFP (Life Technologies Inc.; 1:5,000) followed by 
AlexaFluor-680-conjugated rabbit anti-mouse antibody (1:40,000). Membranes were imaged using Li-






sec61-13myc impairs Clogger translocation  
The attachment of the 13myc epitope tag to Sec61 caused impairment in translocation of the model 
translocon-clogging substrate Deg1*-Sec62. This was inferred based on reduced extent of glycosylation 
of Deg1*-Sec62 when the epitope tag is present (Figure 7B). In sec61-13myc cells, the appearance of a 
faster migrating band visible via SDS-PAGE and western blot represents protein that has not engaged the 
translocon and become glycosylated (which occurs in the ER lumen). To test the impact of sec61-13myc 
on Clogger interaction with the translocon, I analyzed the migration of Clogger in both wild type and 
sec61-13myc cells. I also observed differing glycosylation of Clogger when the 13myc tag is present. In 
wild type cells, the majority of Clogger migrates as a fully glycosylated species (Figure 8). This represents 
Clogger that has fully translocated into the ER. There is also a minor pool of Clogger that has not 
interacted with the translocon, and therefore remains unglycosylated. Very little partially glycosylated, 
translocon-clogged Clogger is present.  
In cells containing sec61-13myc, a greater proportion of Clogger is not fully glycosylated, indicating 
reduced flux through the translocon. In contrast to wild type cells, a substantial proportion of Clogger 
remains partially glycosylated, indicating accumulation of translocon-clogged species. This is different 
than the observed impact of 13myc on Deg1*-Sec62 translocation (Figure 7B). The presence of sec61-
13myc reduced Deg1*-Sec62 interaction with the translocon and clogging frequency, culminating in a 
substantial abundance of protein that that could not interact with the translocon and remained 
unglycosylated. However, in both cases, the addition of 13myc to Sec61 decreased movement of 





sec61-13myc specifically impairs translocation of PTT substrates 
The sec61-13myc modification impairs translocation of two model translocon-clogging substrates, 
Deg1*-Sec62 and Clogger. Both these model substrates translocate through PTT mechanisms. I also 
tested translocation of model PTT and CTT substrates that translocate normally (i.e. without clogging). 
CPY is a model PTT substrate, while OPY is a model CTT substrate (Willer, Forte, and Stirling 2008). In 
sec61-13myc cells, translocation of CPY is impaired (Figure 9). When the epitope tag is not present, CPY 
migrates as one glycosylated species on an SDS-PAGE gel. When the 13myc epitope tag is present, a 
proportion of CPY remains unglycosylated and migrates lower on the gel. This impairment is similar to 
the impaired translocation seen in the clogging PTT substrates, Deg1*-Sec62 and Clogger. In contrast, 
there is no change in OPY glycosylation or migration when the epitope tag is present or absent. This 
suggests that the epitope tag modification sec61-13myc specifically impairs PTT pathways, while leaving 
CTT unperturbed.  
Generation of hrd1 ste24 sec72 yeast 
To determine if impaired PTT rescues the hrd1 ste24 growth defect, I generated a strain that lacked 
both translocon quality control enzymes (Hrd1 and Ste24) and the PTT subunit Sec72. The Rubenstein 
lab possessed a hrd1Δ ste24Δ yeast strain (VJY456; Table 2). SEC72 was knocked out in this strain and 
replaced with a hygromycin B resistance gene (hphMX4). An hphMX4 knockout cassette was amplified 
from plasmid pAG32 (pVJ134; Table 1 (Goldstein and McCusker 1999)) using PCR with flanking 
sequences homologous to sequences immediately upstream and downstream of the SEC72 locus. 
Following yeast transformation, the hphMX4 cassette replaced SEC72 by homologous recombination. 
Stable transformants were selected by growth on media containing hygromycin B. Cells were also 
cultured on media containing G418 as well to confirm the pre-existing knockout of HRD1 (which was 
replaced with the kanMX4 cassette).  
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Insertion of the hygromycin cassette at SEC72 was validated by three-primer PCR at both the 5’ and 3’ 
junctions of the sec72::hphMX4 locus (Figure 10). By performing PCR with primers that amplified 
products of different sizes for the wild type and mutant alleles, the SEC72 genotype was validated at 
both ends of the locus, ensuring the entire gene was replaced during homologous recombination.  A 
strain wild type at the SEC72 locus was used as a negative control. Seven candidate sec72::hphMX4 
clones created through homologous recombination were analyzed by PCR. Five clones yielded PCR 
products at both junctions consistent with SEC72 knockout. Clone 1 (VJY841) was used for subsequent 
experiments. 
Mutation of SEC72 rescues slow growth of hrd1Δ ste24Δ cells. 
Previous experiments demonstrated that eliminating either Hrd1 or Ste24 individually yields no 
observable negative phenotype (Crowder et al. 2015; Ast, Michaelis, and Schuldiner 2016), while 
simultaneously mutating both genes causes a negative growth defect (Runnebohm et al. 2020). 
Modification to the central pore of the translocon via epitope tag (sec61-13myc) fully rescued the hrd1  
ste24 growth defect (Runnebohm et al. 2020). I hypothesize that the sec61-13myc modification to the 
translocon reduces reliance on translocon quality control mechanisms due to impaired engagement 
between the translocon and translocating proteins. Cells lacking SEC72 exhibited no discernable growth 
defects (Figure 11). When the same mutation was introduced in cells lacking Hrd1 and Ste24, cellular 
growth was again rescued, matching results in hrd1Δ ste24 sec61-13myc cells. Thus, two different 
mutations that impair PTT rescue the growth defect associated with impaired translocon quality control. 
sec72Δ reduces frequency of translocation of PTT substrates. 
I also observed translocation efficiency in sec72Δ cells. I analyzed translocation efficiency of three 
translocation substrates: Deg1*-Sec62, CPY, and OPY. Entry of each substrate into the ER results in 
glycosylation, which causes a slower migration by SDS-PAGE (Rubenstein et al. 2012; Runnebohm et al. 
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2020). Mutations of SEC72 mildly increased the proportion of both Deg1*-Sec62 and CPY (which enter 
the translocon via PTT) that remained unglycosylated (Figure 12A and 12B). This indicates that a higher 
proportion of these substrates were unable to engage the translocon and enter the ER. This dysfunction 
is similar to dysfunction observed in sec61-13myc cells (Runnebohm et al. 2020). No dysfunctional 
translocation of OPY was observed in sec72Δ cells (Figure 12C). OPY is a CTT substrate, and Sec72 is only 
necessary for PTT function. Therefore, it is reasonable that OPY would be unaffected by SEC72 mutation. 
Since sec72Δ only affects PTT, dysfunction of PTT is likely sufficient to rescue the negative phenotype 
associated with impaired translocon quality control. I note that the effect of SEC72 deletion on CPY 
translocation is mild. However, this modest reduction in translocation efficiency is reproducible. A 
second experiment demonstrating impaired translocation of CPY in sec72 cells is illustrated in Figure 
12D. 
GFP-tagged translocon subunits cause varying dysfunction of PTT  
Yeast possessing several different GFP-tagged translocon subunits were analyzed for translocation 
efficiency of three model translocating substrates: Deg1*-Sec62, CPY, and OPY (Figure 13). Tagged 
translocons with wild type function may be used in translocon immunoprecipitation experiments to 
identify physiological translocon-clogging proteins. sec61-13myc cells were used as a positive control for 
dysfunctional PTT. sec63-GFP and sec61-GFP both caused accumulation of unglycosylated and likely 
untranslocated PTT substrates Deg1*-Sec62 and CPY (Figure 13A, 13B), but did not alter modification of 
CTT substrate OPY (Figure 13C). The tagged translocon subunit sss1-GFP reduced the steady state 
abundance of all three substrates tested (Figure 13A, 13B, 13C). This would not be an ideal choice for 
use in immunoprecipitation experiments. Sec71-GFP and Sec72-GFP did not impact apparent PTT of 
Deg1*-Sec62 and CPY or CTT of OPY. Either Sec71-GFP or Sec72-GFP would potentially be a good 




I also tested sss1-3HA for translocation efficiency of Deg1*-Sec62, CPY, and OPY (Figure 14). Sss1 is the 
smallest subunit of the translocon, is a component of the central heterotrimer, and the HA epitope tag is 
smaller than GFP or 13myc (Esnault et al. 1993; Zappelli et al. 2014). However, sss1-3HA caused worse 
translocation function than sss1-GFP, as demonstrated by increased abundance of unglycosylated and 
likely untranslocated species of PTT substrates Deg1*-Sec62 and CPY. Translocation of CTT substrate 






Our experiments show that modification to the translocon can have significant effects on translocation 
into the ER and impact cellular health in the context of impaired translocon quality control. Previous 
experiments have shown that the translocon modification sec61-13myc both impairs translocon 
clogging by Deg1*-Sec62 , which occurs by the PTT mechanism, and rescues cellular health in cells 
lacking translocon quality control machinery (Runnebohm et al. 2020). I observed that the sec61-13myc 
modification also impaired translocation of a second model clogging PTT substrate, Clogger, as well as 
the model PTT substrate CPY. sec61-13myc did not impair translocation of model CTT substrate OPY.  
I was able to replicate these phenotypes in cells lacking Sec72. Sec72 is a translocon subunit that is 
required for efficient PTT. sec72Δ cells exhibit reduced clogging by Deg1*-Sec62, impaired PTT, and 
robust cellular health when translocon quality control is impaired. I also show that other modifications 
to the translocon impair translocation of PTT substrates. C-terminal GFP epitope tags of translocon 
subunits Sec61, Sss1, and Sec63 impaired translocation of model clogging substrate Deg1*-Sec62 and 
model PTT substrate CPY. The addition of the epitope tag HA to the Sss1 subunit also caused impairment 
of Deg1*-Sec62 and CPY. However, GFP epitopes attached to Sec71 or Sec72 did not cause impairment 
of Deg1*-Sec62 or CPY translocation. In addition, no tested epitope tag configurations caused 
translocation impairment of model CTT substrate OPY.  
Why does loss of Hrd1 and Ste24 cause a growth defect? 
In cells expressing either functional Hrd1 or Ste24, there is no discernable growth phenotype compared 
to wild type (Ast, Michaelis, and Schuldiner 2016; Crowder et al. 2015; Kaneko et al. 2016). However, 
when both proteins are missing, cells exhibit a strong negative growth phenotype. This strongly suggests 
an overlapping function between Hrd1 and Ste24 that is not performed when both proteins are missing. 
This is likely a function in ER translocon quality control, as this is a known overlapping function of both 
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proteins. A natural translocon-clogging protein, for instance, may be cleared by either Hrd1 or Ste24. In 
cells without either translocon quality control measure, translocon clogging is unable to be resolved, 
and cellular health decreases. This hypothesis is supported by observations of increased stabilization 
(Deg1*-Sec62) or abundance (Clogger) of model translocon-clogging proteins in hrd1Δ ste24Δ cells than 
in single mutants (Runnebohm et al. 2020). The hrd1Δ ste24Δ double mutant is unable to completely 
stabilize either model protein, suggesting still other pathways may contribute to translocon quality 
control.  
However, Hrd1 and Ste24 perform other functions in the cell beside their roles in translocon quality 
control. Hrd1 ubiquitylates several different categories of proteins in the ER membrane and lumen, 
including many that do not clog translocons. These functions are collectively known as ER-associated 
degradation (ERAD) (Rubenstein et al. 2012). Ste24 protease also cleaves other proteins that do not 
aberrantly engage the translocon. Along with translocon quality control, Ste24 cleaves proteins 
possessing CAAX boxes. This allows for maturation of proteins at the ER (Ast, Michaelis, and Schuldiner 
2016). These other functions of Hrd1 and Ste24 have not been isolated from their translocon quality 
control function in these experiments. Therefore, further testing must be done to discern how much of 
the observed phenotypes are due to the roles Hrd1 and Ste24 play at the translocon versus other 
functions of these two proteins. This could be done through targeted knockout of accessory proteins 
that are involved in the different functions of these two proteins. If I see the same phenotypes both with 
and without these accessory proteins, the phenotypes are most likely due to action of Hrd1 and Ste24 at 
the translocon.  
 
 
Impaired post-translational translocation rescues the negative growth phenotype of hrd1 ste24 cells. 
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To further characterize hrd1Δ ste24Δ cells, I introduced a 13myc epitope tag to the Sec61 subunit of the 
translocon. This had the unintended consequence of rescuing the negative growth phenotype observed 
in hrd1Δ ste24Δ cells. Further investigation showed that the addition of this tag to the translocon also 
caused a population of PTT substrates (but not of a model CTT substrate) to fail to efficiently engage the 
translocon, as indicated by a reduction of glycosylation of these proteins.  
I hypothesized the reduced translocation in sec61-13myc cells led to more robust cellular health when 
translocon quality control machinery was absent. This was supported in similar experiments using 
sec72Δ cells. Western blot analysis showed that translocation of Deg1*-Sec62, Clogger, and CPY (all PTT 
substrates) was impaired in sec72Δ cells. The impairment of translocation was smaller than that 
observed in Sec61-13myc cells. However, this phenotype was consistent and shows that both 
modifications to the translocon specifically impair translocation of PTT substrates.  
sec72Δ cells exhibit similar growth phenotypes to cells expressing sec61-13myc in the context of 
impaired translocon quality control. In both cases, when translocation is impaired, cells become less 
reliant on translocon quality control machinery for optimal growth. It is possible that impaired PTT 
reduces the number of clogging events happening in the cell at any one time. For instance, a naturally 
clogging protein may only clog during a small number of individual translocation events.  PTT 
impairment may lower the overall instances of translocon clogging of these proteins by reducing the 
number of total PTT translocation events. With fewer instances of translocon clogging, there would be 
reduced need for the translocon quality control proteins Hrd1 and Ste24. In turn, this would lead to 
increased cellular health in cells with impaired translocation in the context of HRD1 and STE24 deletion.  
While modifications to the translocon caused impaired translocation of model PTT substrates, 
translocation of the model CTT substrate OPY was unaffected by any translocon modification tested. 
This indicates that these translocon modifications specifically inhibit translocation of PTT substrates. 
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From this, I can infer the likely translocon-clogging protein targets of Hrd1 and Ste24: proteins that enter 
the ER via PTT. I speculate that accumulation of PTT substrates clogging wild type translocons when 
translocon quality control is impaired leads to poor cellular health by impairing the movement of other 
proteins into the ER. This suggests that Hrd1- and Ste24-mediated degradation of translocon-clogging 
PTT substrates is vital to cellular health.  
Consistent with a specific role in targeting PTT translocon-clogging proteins, Hrd1 and Ste24 do not 
contribute to the degradation of model translocon-clogging substrates that use the CTT pathway 
(Crowder et al. 2015)(Kennedy, Rubenstein unpublished data). In these studies, the engineered protein 
OPY-K12 was utilized to simulate a CTT clogging protein. OPY is a model CTT protein. By adding multiple 
positive lysine residues to the C-terminus of the protein, the amino acid sequence aberrantly interacts 
with the negatively charged exit channel of the ribosome, stalling the newly formed protein in the 
ribosome. As the protein simultaneously engages the ribosome and translocon, the translationally 
stalled protein also remains stalled in the translocon. These stalled proteins are degraded through the 
UPS and the E3 ligase Rkr1/Ltn1. However, Hrd1 and Ste24 do not participate in the degradation of this 
model CTT clogging protein, suggesting that Hrd1 and Ste24 may only be used in protein quality control 
of the PTT translocon.   
How do sec61-13myc and sec72Δ cause impairment of translocation? 
Both sec61-13myc and sec72Δ specifically impair PTT. This is most likely due to changes in interactions 
among specific subunits of the PTT translocon. PTT requires multiple subunit interactions to facilitate 
the transfer of nascent proteins to the Sec61 pore and further translocation. The proteins considered 
part of the PTT translocon are Sec61, Sss1, Sbh1, Sec62, Sec63, Sec71 and Sec72.  Subtle perturbation of 
interactions between translocon subunits or between the translocon and the translocating protein may 
explain translocation impairment of PTT substrates.  
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In cells expressing sec61-13myc, the epitope tag is attached at the at the C-terminus of Sec61 (Carvalho, 
Stanley, and Rapoport 2010). Sec61 contains ten transmembrane segments with both the N- and C-
termini on the cytosolic side of the ER membrane (Linxweiler, Schick, and Zimmermann 2017). While 
Sec62 binds to the N-terminus of Sec61, Sec63 binds to cytosolic loops 6 and 7 of Sec61. These loops are 
in close proximity to loops 8 and 9 of Sec61 (Wu 2019). Binding of Sec62 and Sec63 cause 
conformational changes to Sec61 that facilitate translocation of PTT substrates. Mutation of SEC63 
inhibits translocation of some model PTT substrates, while having no effect on others (Lang 2012; 
Gorlich 1993). The addition of a 13myc tag to the C-terminal end of Sec61 may sterically disrupt the 
interaction between Sec63 and Sec61. Since PTT of model substrates Deg1*-Sec62, Clogger, and CPY is 
only partially impaired, the presence of 13myc may weaken, but not abolish, the Sec61-Sec63 
interaction. Flexibility in the 13myc epitope may result in a transient translocation block, or inhibition of 
a subset of translocon complexes (Figure 15).  
Sec72 is another component of the PTT translocon, with a primary function of recognizing proteins 
bound to cytosolic Hsp70 (Wu 2019). This cytosolic protein is recruited to the translocon by Sec63, along 
with the integral membrane protein Sec71. Sec72 and Sec71 (which are not present in higher organisms) 
are not essential for PTT (Wu 2019). However, deletion of SEC72 modestly impairs translocation of PTT 
substrates Deg1*-Sec62, CPY, and Clogger. The impairment is likely due to the translocon not being able 
to recognize PTT substrates as efficiently without Sec72 being able to recruit Hsp70-bound PTT 
substrates. The reproducible impairment is milder than the impairment in Sec61-13myc cells. The milder 
effect is likely due to the non-essential nature of Sec72 compared to the interaction between Sec61 and 
Sec63. 
Which tagged translocon subunits do not cause translocation impairment? 
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To identify an epitope-tagged translocon with unimpaired translocation, I analyzed the function of cells 
expressing various translocon subunits with a GFP epitope. Along with GFP-tagged translocons, I also 
created one 3HA-tagged translocon to test for translocation efficiency. Similar to sec61-13myc and 
SEC72 deletion, none of the epitope-tagged translocons tested affected translocation of model CTT 
substrate OPY. Translocation of model PTT substrates Deg1*-Sec62 and CPY was differentially affected 
by epitopes linked to different translocon subunits. Modification of Sec61, Sec62, Sec63, and Sss1 
subunits caused impairment of PTT, while modification to Sec71 and Sec72 caused little impairment.  
Of all the subunit-epitope combinations tested, tags attached to the Sec61 and Sss1 subunits showed 
the most impairment of PTT. Both subunits contribute to the central pore of the translocon, suggesting 
that even slight perturbation to the central pore could impair function. Sec71 and Sec72 are the most 
peripheral subunits of the translocon, which may explain the minimal impact of tagging these proteins. 
However, an epitope on a subunit contributing to the central pore that mildly impairs PTT may still be 
useful in experiments designed to identify physiological translocon-clogging proteins. In the presence of 
all tested epitopes, a substantial amount of PTT substrate translocates into the ER and becomes 
glycosylated, and a substantial fraction of Clogger protein clogged the translocon in cells expressing 
sec61-13myc. This suggests that clogging proteins (which likely predominantly enter the translocon via 
PTT) may be isolated through co-immunoprecipitation experiments using tags close to the central pore. 
Attaching the tag to the central pore also has advantages compared to tagging more peripheral 
subunits, such as Sec71 or Sec72. By attaching the tag to a peripheral subunit of the translocon, the 
interaction between this subunit and the central pore must be maintained to precipitate clogging 
proteins. Attaching the epitope tag to the central pore of the translocon will bypass this issue, 
potentially allowing for more efficient isolation of physiological translocon-clogging proteins.  
Conclusions and future directions 
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This research reveals modifications to the ER translocon that specifically impair PPT, and how this 
impairment leads cells to have less reliance on the translocon quality control pathways mediated by 
Hrd1 and Ste24. This could lead to new discoveries and therapies for diseases that have been correlated 
with clogged translocons, such as cholesterol and diabetes. Apolipoprotein B (ApoB) is a known 
translocon-clogging protein that is regulated by Gp78, the mammalian Hrd1 homolog (Yeung, Chen, and 
Chan 1996). ApoB interacts with and clogs the translocon, waiting for lipids in the ER lumen to bind and 
create LDL molecules. If lipids do not bind to translocon-engaged ApoB, Gp78 ubiquitylates ApoB, 
leading to its degradation, allowing the translocon to resume normal function. Dysfunction in this 
system can lead to problems in cholesterol metabolism and cardiovascular disease in mammals. Future 
experiments will be performed to determine if Ste24 (or mammalian homolog ZMPSte24) contributes to 
ApoB regulation and cholesterol metabolism. The overlapping function of Hrd1 and Ste24 suggests that 
targeting ZMPSte24 or Gp78 may represent viable strategies for treating cholesterol-related disease. 
Diabetes also can be regulated through actions at the translocon. Type 2 diabetes is characterized by 
insulin resistance and β cell dysfunction. One of the causes of β cell dysfunction is misfolding and 
aggregation of a normally secreted protein, islet amyloid polypeptide (IAPP). Recent studies indicate 
that the pathologic impact of this protein may be mediated in part through translocon clogging by the 
aggregated form of IAPP. Toxicity associated with this protein is modulated by ZMPSte24, which may 
target the protein for degradation (Kayatekin 2018). Similar to ApoB in cholesterol function, it is 
unknown whether Gp78 also has an overlapping role in the regulation of IAPP. Ste24, and potentially 
Gp78, are potential targets for new strategies in diabetes therapy and prevention.  
Many questions remain unanswered regarding the relationship between Hrd1 and Ste24 in translocon 
quality control. Both Hrd1 and Ste24 have many functions outside their roles as translocon quality 
control. It is possible that disruption of these other functions in hrd1Δ ste24Δ cells have some effect on 
the negative growth phenotype observed in these cells. Moreover, whether Hrd1 cofactors that 
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contribute to degradation of misfolded Hrd1 substrates are also required for its function in translocon 
quality control is not known. More research needs to be done to untangle the varying roles of these 
enzymes to further understand their roles in translocon quality control.  
A better understanding of the features of translocon-clogging proteins recognized by Hrd1 and Ste24 
homologs, facilitated by identification of physiological translocon-clogging proteins, may inform 
strategies to treat medical conditions associated with clogged translocons. The work presented here has 
relied on two model translocon-clogging proteins to study translocon quality control: Deg1*-Sec62 and 
Clogger. While these engineered proteins have proven useful, they may not interact with the translocon 
or translocon quality control in the same way as natural clogging proteins. In the future, I would like to 
identify novel, natural translocon-clogging proteins through co-immunoprecipitation and proteomics-
based identification. Based on the epitope-tagged translocons tested, Sec71-GFP and Sec72-GFP cause 
the least impaired translocation. However, sec61-13myc retains sufficient translocon function and 
would likely prove useful in co-immunoprecipitation experiments. Purifying a central pore subunit may 
prove more successful in enrichment of translocon-clogging proteins than precipitating a peripheral 
subunit of the translocon. I hope that the discovery of novel translocon-clogging proteins will lead to 
new insights about the nature of translocon-clogging proteins, potentially leading to new strategies for 
treating diseases associated with translocon clogging, such as cholesterol-related pathology and 




Table 1. List of plasmids used in this study 




pVJ27 pRS316 empty vector URA3 AmpR 








































Table 2. List of yeast strains used in this study 
Yeast Number Alias  Genotype 
VJY6 MHY500 his3-Δ200, leu2-3-112, ura3-52, lys2-801, trp1-1, 
gal2 
VJY18 MHY7659 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sec61-
13myc::HISMX6 
VJY260 MHY7582 (105-3-2) his3-Δ200, leu2-3-112, ura3-52, lys2-801, trp1-1, 
gal2, sec61-13myc-TRP1 
VJY456  his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, hrd1Δ::kanMX, 
ste24Δ::natMX4 
VJY462  his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, hrd1Δ::kanMX4, 
ste24Δ::HygroR, sec61-13myc::HISMX6 
VJY476 YSC1048, BY4741 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 
VJY588 YKM936 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sec63-EGFP-
kanMX4 
VJY765  his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sec61-
GFP::HIS5sp 
VJY766   his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sss1-GFP::HIS5sp 
VJY767  his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sec71-
GFP::HIS5sp 
VJY783  his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sec72-
GFP::HIS5sp 
VJY786  his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sec72Δ::hphMX4 
VJY803  his3-Δ200, leu2-3-112, ura3-52, lys2-801, trp1-1, 
gal2, sss1-3HA::His3MX6 








Figure 1. Different mechanisms of translocation into the ER lumen. During co-translational 
translocation (CTT), polypeptide chains are simultaneously translated by the ribosome and translocated 
into the ER. During post-translational translocation (PTT), translation occurs independently of 
translocation. After translation is completed in the cytosol, the newly formed polypeptide is transported 

















Figure 2. The Ubiquitin-Proteasome System. A ubiquitin-activating enzyme (E1) transfers a ubiquitin 
molecule to a ubiquitin-conjugating enzyme (E2). A ubiquitin ligase enzyme (E3) then recruits the 
charged E2 to a protein targeted for degradation. The E3 is also responsible for facilitating the transfer 
of the ubiquitin molecule from the E2 to the targeted protein. After consecutive ubiquitin molecules 
have been transferred to the targeted protein, the protein is then targeted by the proteasome for 
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Figure 3. ER-associated degradation of translocon-clogging proteins mediated by the E3 ubiquitin 
ligase Hrd1. The E3 ligase Hrd1 attaches ubiquitin to protein molecules that clog the translocon. The 







Figure 4. Ste24 protease cleaving stalled proteins from the translocon. Ste24 is a protease enzyme that, 






Figure 5. Ribosome-associated degradation mediated by Rkr1/Ltn1. As proteins stall in the translocon 
during translation, Rkr1/Ltn1 is recruited to the dysfunctional ribosome and ubiquitylates the offending 
protein. The ubiquitylated protein is then removed from the translocon and transported to the 











Figure 6. Schematic of Deg1-Sec62 and Clogger interaction with the translocon. (A) Deg1-Sec62 
consists of the degron Deg1 from Matα2 fused to the N-terminus of the translocon subunit Sec62. This 
fusion causes the cytosolic portion of the N-terminus to loop into the central pore of the ER and 
aberrantly interact with the translocon. There is one glycosylation site in the portion of Deg1-Sec62 that 
is exposed to the ER lumen.  (B) Clogger is a fusion of the PTT substrate Pdi1, and the E. coli enzyme 
dihydrofolate reductase (DHFR). DHFR rapidly folds, causing steric hindrance at the translocon. Clogger 

















Figure 7. sec61-13myc causes impairment of the translocon (A) Six-fold serial dilutions of yeast of the 
indicated genotypes were spotted onto rich growth medium and incubated at 30oC. (B) Protein 
abundance and mobility of Deg1*-Sec62  in wild type cells and sec61-13myc cells. As Deg1*-Sec62 
interacts with and clogs the translocon, it is modified via N-linked glycosylation. Impairment of the 
translocon leaves Deg1*-Sec62 unmodified. Modifed (clogged) and unmodified (unclogged) Deg1*-
Sec62 travel as two discrete species. Pgk1 is used as a loading control.  
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Figure 8. sec61-13myc modification causes impairment of translocation of Clogger protein. Protein 
abundance and migration of Clogger were analyzed in wild type cells and sec61-13myc cells. As 
translocating substrate interacts with the translocon, it is modified via N-linked glycosylation. Impaired 
translocation resuls is substrate molecules with fewer modifcations. Differences in translocation result 
in species that migrate as discrete bands. Clogger was detected by western blot with antibodies that 
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Figure 9. sec61-13myc modification causes impairment of translocation of model PTT substrate. 
Protein abundance and migration of model PTT substrate CPY and model CTT substrate OPY were 
analyzed in wild type cells and sec61-13myc cells. As translocating substrate interacts with the 
translocon, it is modified via N-linked glycosylation. Impaired translocation resuls is substrate molecules 
with fewer modifcations. Substrates with varying modifications migrate as discrete bands. CPY and OPY 
was detected by western blot with antibodies that bind to a C-terminal ProtA epitope tag. Pgk1 was 
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Figure 10. Validation of SEC72 genotype in hrd1Δ ste24Δ sec72Δ strains. (A) Seven candidate hrd1Δ 
ste24Δ sec72Δ clones were genotyped at the 3’ end of the SEC72 locus. Wild type expected product size: 
501 bp. sec72Δ expected product size: 615  p.      alidated clones from the 3’ end were then analyzed 
at the 5’ end of the SEC72 locus. Wild type expected product size: 601 bp. sec72Δ expected product size: 







Figure 11. SEC72 deletion rescues negative growth phenotype of hrd1Δ ste24Δ cells. Six-fold serial 





Figure 12. SEC72 deletion causes dysfunction of the translocon. (A) Protein abundance and migration of 
of Deg1*-Sec62 were analyzed in wild type cells and sec72Δ cells. (B, D) Protein abundance and 
migration of CPY were analayzed in wild type cells and sec72Δ cells. (C) Protein abundance and 
migration of OPY were analyzed in wild type cells and sec72Δ cells. (A-D) As translocating substrates 
interact with the translocon, they become modified via N-linked glycosylation. Impaired translocation 
results in hypomodified substrate. Modifed and unmodified substrate travel as discrete bands. DS, CPY, 
and OPY were detected by western blot with antibodies that bind to a C-terminal Protein A epitope tag. 
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Figure 13. Impact of the addition of C-terminal GFP tag on translocon subunits on translocon 
engagement. (A) Protein abundance and migration of Deg1*-Sec62  were analyzed in wild type cells, 
sec61-13myc cells, and cells containing indicated GFP-tagged translocon subunit. (B) Protein abundance 
and migration of CPY were anlyzed in wild type cells, sec61-13myc cells sec72Δ cells, and cells containing 
indicated GFP-tagged translocon subunit. (C) Protein abundance and migration of OPY were anlayzed in 
wild type cells , sec72Δ cells, and cells containing indicated GFP-tagged translocon subunit. Deg1*-
Sec62, CPY, and OPY were detected by western blot with antibodies that bind to a C-terminal Protein A 





Figure 14. sss1-3HA causes dysfunction of translocation. Protein abundance and migation of Deg1*-
Sec62, CPY, and OPY were analyzed in wild type, sec61-13myc, and sss1-3HA cells. As translocating 
substrates interact with the translocon, they become modified via N-linked glycosylation. Impaired 
translocation results in hypomodified substrate. Modifed and unmodified substrate travel as discrete 
bands. Deg1*-Sec62, CPY, and OPY were detected by western blot with antibodies that bind to a C-





Figure 15. The C-Terminus of Sec61 is important to efficient subunit interactions. Ribbon diagram of 
the PTT translocon (reproduced from (Wu, Cabanos, and Rapoport 2019). The C-terminal end of Sec61 is 
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